Clinical trial harmonisation needed, but pharma wary of EU project
This article was originally published in Scrip
Executive Summary
Pharmaceutical companies are wary of participating in a voluntary pilot project run by the Heads of Medicines Agencies, which aims to harmonise the procedure for the assessment of multinational clinical trial applications made in EU member states, delegates heard at the recent European Medicines Agency/Topra meeting.